Billede af Per thor Straten
1994 …2020

Publikationer pr. år

Netværk

Manja Idorn

  • University of Copenhagen
  • Kobenhavns Universitet

Ekstern person

Eva Ellebaek

  • University of Copenhagen

Ekstern person

Tina Seremet

  • University of Copenhagen

Ekstern person

Marco Donia

  • University of Copenhagen

Ekstern person

Anne Rahbech

  • University of Copenhagen

Ekstern person

Jordi Rodon

  • Autonomous University of Barcelona
  • University of Texas MD Anderson Cancer Center

Ekstern person

Amalie Kai Bentzen

  • Technical University of Denmark

Ekstern person

Hans-Georg Rammensee

  • University of Tübingen
  • German Cancer Research Center

Ekstern person

Francisco Martínez-Ricarte

  • Autonomous University of Barcelona

Ekstern person

Sofie Ramskov

  • Technical University of Denmark

Ekstern person

Evelina Martinenaite

  • University of Copenhagen
  • Copenhagen University Hospital, Koege
  • IO Biotech ApS

Ekstern person

Norbert Hilf

  • Immatics Biotechnologies GmbH

Ekstern person

Bracha Shraibman

  • Technion-Israel Institute of Technology

Ekstern person

Trine Zeeberg Iversen

  • University of Copenhagen

Ekstern person

Sabrina Kuttruff-Coqui

  • Immatics Biotechnologies GmbH

Ekstern person

Berta Ponsati

  • BCN Peptides

Ekstern person

Sebastian Kreiter

  • BioNTech Ag
  • working group Cancer Immunoguiding Program

Ekstern person

Jon Amund Kyte

  • University of Oslo

Ekstern person

David Schrama

  • Medical University of Graz
  • University of Würzburg

Ekstern person

Paolo A Ascierto

  • IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli

Ekstern person

Ghazaleh Tabatabai

  • University of Tübingen
  • German Cancer Research Center

Ekstern person

Sjoerd H. van der Burg

  • working group Cancer Immunoguiding Program
  • Leiden University

Ekstern person

Katrin Frenzel

  • BioNTech Ag
  • Neuruppin Bonn

Ekstern person

Pierre Yves Dietrich

  • University of Geneva

Ekstern person

Judith R. Kroep

  • Leiden University

Ekstern person

Valerie Dutoit

  • University of Geneva

Ekstern person

Juan Sahuquillo

  • Autonomous University of Barcelona

Ekstern person

Troels Holz Borch

  • University of Copenhagen
  • Kobenhavns Universitet

Ekstern person

Henrik Schmidt

  • University of Southern Denmark
  • Aarhus University

Ekstern person

Cathrin Ritter

  • University of Duisburg-Essen
  • German Cancer Consortium (DKTK)
  • German Cancer Research Center

Ekstern person

Andreas von Deimling

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

John C. Castle

  • BioNTech Ag
  • Agenus

Ekstern person

Cedrik M. Britten

  • BioNTech Ag
  • working group Cancer Immunoguiding Program
  • GlaxoSmithKline

Ekstern person

Michael Platten

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

Hideho Okada

  • University of California at San Francisco
  • Parker Institute for Cancer Immunotherapy

Ekstern person

Ugur Sahin

  • BioNTech Ag

Ekstern person

Wolfgang Wick

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

Arie Admon

  • Technion-Israel Institute of Technology

Ekstern person

Colette Song

  • Immatics Biotechnologies GmbH

Ekstern person

Marlies J.W. Peeters

  • University of Copenhagen

Ekstern person

Christian H. Ottensmeier

  • University of Southampton

Ekstern person

Christian Blank

  • Netherlands Cancer Institute

Ekstern person

Pavel Gromov

  • Danish Cancer Society
  • Danish Ctr. Translational B. C. R.
  • Danish Centre for Translational Breast Cancer Research

Ekstern person

Katja Harbst

  • Lund University

Ekstern person

Denis Sasseville

  • McGill University

Ekstern person

Nina Pawlowski

  • Immatics Biotechnologies GmbH

Ekstern person

Caroline H Riley

  • University of Copenhagen

Ekstern person

Jörg Ludwig

  • Immatics Biotechnologies GmbH

Ekstern person

Stefan Stevanović

  • University of Tübingen
  • German Cancer Research Center

Ekstern person

Pieter Spee

  • PS Pharmaconsult

Ekstern person

Claudia Wagner

  • Immatics Biotechnologies GmbH

Ekstern person

Anneline Nansen

  • Novo Nordisk A/S (Biz)
  • Zealand Pharma A/S (Biz)

Ekstern person

Franziska Hoffgaard

  • Immatics Biotechnologies GmbH

Ekstern person

Monika Stieglbauer

  • University of Tübingen
  • working group Cancer Immunoguiding Program

Ekstern person

Mattias F Lindberg

  • University of Gothenburg

Ekstern person

Linda Cairns

  • IRCCS Istituto Europeo di Oncologia - Milano

Ekstern person

Andrea Anichini

  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano

Ekstern person

Sandra Heesch

  • BioNTech Ag

Ekstern person

Christoph Huber

  • BioNTech Ag

Ekstern person

Vibeke Mindahl Rafa

  • Technical University of Denmark

Ekstern person

Tim Fugmann

  • Philochem AG
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Ekstern person

Regina Mendrzyk

  • Immatics Biotechnologies GmbH

Ekstern person

Carsten Reinhardt

  • Immatics Biotechnologies GmbH

Ekstern person

Nadia Viborg

  • Technical University of Denmark

Ekstern person

Nigel P Mongan

  • Weill Cornell Medicine
  • University of Nottingham

Ekstern person

Martin Lauss

  • Lund University

Ekstern person

Ana Micaela Carnaz Simoes

  • University of Copenhagen

Ekstern person

Lauge Kellermann

  • University of Copenhagen

Ekstern person

Jonas A Nilsson

  • University of Gothenburg

Ekstern person

Toni Weinschenk

  • Immatics Biotechnologies GmbH

Ekstern person

Denis Migliorini

  • University of Geneva

Ekstern person

Harpreet Singh-Jasuja

  • Immatics Biotechnologies GmbH

Ekstern person

Jens Fritsche

  • Immatics Biotechnologies GmbH

Ekstern person

Henrik Ipsen

  • ALK-Abelló

Ekstern person

Per Kongsted

  • University of Copenhagen

Ekstern person

Irina Gromova

  • Danish Cancer Society
  • Danish Ctr. Translational B. C. R.
  • Danish Centre for Translational Breast Cancer Research

Ekstern person

Sonja Dorner

  • Immatics Biotechnologies GmbH

Ekstern person

Alexander Ulges

  • Immatics Biotechnologies GmbH

Ekstern person

Göran Jönsson

  • Lund University

Ekstern person

Lone Duval

  • Aarhus University

Ekstern person

Gitte Holmen Olofsson

  • University of Copenhagen

Ekstern person

Ahmad Awada

  • Université libre de Bruxelles

Ekstern person

Arbel D. Tadmor

  • Johannes Gutenberg University Mainz

Ekstern person

Hans Carl Hasselbalch

  • Zealand University Hospital, Køge

Ekstern person

Julio E. Celis

  • Danish Cancer Society
  • Danish Ctr. Translational B. C. R.
  • Danish Centre for Translational Breast Cancer Research

Ekstern person

Jenny L. Persson

  • Umeå University
  • Lund University

Ekstern person

Katharina Kiesel

  • Immatics Biotechnologies GmbH

Ekstern person

Ivan V Litvinov

  • McGill University
  • University of Ottawa

Ekstern person

Sascha Ott

  • Uppsala University

Ekstern person

David Capper

  • Heidelberg University 
  • German Cancer Research Center
  • Charité – Universitätsmedizin Berlin

Ekstern person

Valesca Bukur

  • BioNTech Ag

Ekstern person

Katy McCann

  • University of Southampton

Ekstern person

Lukas Bunse

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

Eugene Lukanidin

  • Kræftens Bekæmpelse

Ekstern person

Marco Skardelly

  • University of Tübingen

Ekstern person

Selma Ugurel-Becker

  • University of Duisburg-Essen

Ekstern person

Mariusz Wasik

  • University of Pennsylvania

Ekstern person

Jeurgen C. Becker

  • University of Duisburg-Essen

Ekstern person

Nicolle Rekers

  • Maastricht University

Ekstern person

Miriam Meyer

  • Immatics Biotechnologies GmbH

Ekstern person

Elisa Rusch

  • University of Tübingen
  • working group Cancer Immunoguiding Program

Ekstern person

Martin Löwer

  • BioNTech Ag

Ekstern person

Lluis M Mir

  • Université Paris-Saclay

Ekstern person

Shamaila Munir Ahmad

  • University of Copenhagen
  • Copenhagen University Hospital, Koege

Ekstern person

Jens Brimnes

  • Statens Serum Institut

Ekstern person

Sandrine Aspeslagh

  • Université Paris-Sud

Ekstern person

Sunil Kumar Saini

  • Danmarks Tekniske Universitet

Ekstern person

Gitte Holmen Olofsson

  • University of Copenhagen

Ekstern person

Caroline Hasselbalch Riley

  • University of Copenhagen

Ekstern person

Oliver Schoor

  • Immatics Biotechnologies GmbH

Ekstern person

Theo Sturm

  • Philochem AG

Ekstern person

Edward Green

  • German Cancer Research Center
  • Heidelberg University 

Ekstern person

Cécile Gouttefangeas

  • University of Tübingen
  • German Cancer Research Center
  • working group Cancer Immunoguiding Program

Ekstern person

Per Thor Straten

  • University of Copenhagen

Ekstern person

Christine Dethlefsen

  • Copenhagen University Hospital, Koege

Ekstern person

Sergei B Koralov

  • New York University

Ekstern person

Bernhard Rössler

  • Immatics Biotechnologies GmbH

Ekstern person

Teresa Cabezon

  • Danish Ctr. Translational B. C. R.
  • Danish Cancer Society
  • Danish Centre for Translational Breast Cancer Research

Ekstern person

Dorte Kinggaard Holm

  • Danish Ctr. Translational B. C. R.
  • Copenhagen University Hospital, Koege
  • University of Southern Denmark

Ekstern person

Rikke Lyngaa

  • University of Copenhagen

Ekstern person

Aron Charles Eklund

  • Center for Biological Sequence Analysis, Technical University of Denmark
  • Danmarks Tekniske Universitet

Ekstern person

Jordi Piró

  • BCN Peptides

Ekstern person

Donata Dulkeviciute

  • University of Copenhagen

Ekstern person

Marij J.P. Welters

  • working group Cancer Immunoguiding Program
  • Leiden University

Ekstern person

Elisabeth D Galsgaard

  • Novo Nordisk A/S (Biz)

Ekstern person

Arianna Draghi

  • Kobenhavns Universitet
  • University of Copenhagen

Ekstern person

Dominik Maurer

  • Immatics Biotechnologies GmbH

Ekstern person